Management of hemophilia in resource-limited countries

Transfusion Alternatives in Transfusion Medicine

Volumn 10, Issue 2, 2008, Pages 70-74

  Ayob, Yasmin ^a  

^a National Blood Centre   (Malaysia)

Author keywords

Factor replacement; Hemophilia; Management protocols; National program

Indexed keywords

AMINOCAPROIC ACID; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR CONCENTRATE; DESMOPRESSIN; FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

ARTICLE; AWARENESS; BLEEDING DISORDER; BLOOD TRANSFUSION; DEVELOPING COUNTRY; ETHNICITY; FINANCE; GOVERNMENT; HEALTH CARE PLANNING; HEMOPHILIA; HUMAN; LEADERSHIP; ORGANIZATION; PATIENT CARE; PLASMA TRANSFUSION; PREVALENCE; PRIORITY JOURNAL; RACE; RARE DISEASE; RESOURCE MANAGEMENT; SOCIOECONOMICS; SUBSTITUTION THERAPY;

EID: 65249111080     PISSN: 12959022     EISSN: 1778428X     Source Type: Journal    
DOI: 10.1111/j.1778-428X.2008.00108.x     Document Type: Article

References (18)

1. Bolton-Maggs PH. Optimal haemophilia care versus the reality. Br J Haematol 2006; 132: 671-82.
2. O'Mahony B. Keep factor concentrates on essential medicines list. Hemophilia World 2003; 10: 45-6.
3. Stonebraker JS, Amand RE, Nagle AJ. A country-by-country comparison of FVIII concentrate consumption and economic capacity for the global haemophilia community. Haemophilia 2003; 9: 245-50.
4. Srivastava A. Optimizing clotting factor replacement therapy in hemophilia: A global need. Hematology 2005; 10 (Suppl. 1): 229-30.
5. Spilsbury M. Models for psychosocial services in the developed and developing world. Haemophilia 2004; 10 (Suppl. 4): 25-9.
6. World Federation of Hemophilia. Report on the Global Survey 2004. Accessed at http://www.wfh.org/2/7/7_0_Link7_GlobalSurvey2004.htm (last accessed 11 April 2007).
7. Tezanos Pinto M, Ortiz Z. Haemophilia in the developing world: successes, frustrations and opportunities. Haemophilia 2004; 10(Suppl. 4): 14-19.
8. Isarangkura P. Haemophilia care in the developing world: Benchmarking for excellence. Haemophilia 2002; 8: 205-10.
9. Antunes SV. Haemophilia in the developing world: The Brazilian experience. Haemophilia 2002; 8: 199-204.
10. Srivastava A, You SK, Ayob Y, et al. Hemophilia treatment in developing countries: Products and protocols. Semin Thromb Hemost 2005; 31: 495-500.
11. Manco-Johnson MJ, Nuss R, Geraghty S, Funk S, Kilcoyne R. Results of secondary prophylaxis in children with severe hemophilia. Am J Hematol 1994; 47: 113-17.
12. Petrini P, Lindvall N, Egberg N, Blombäck M. Prophylaxis with factor concentrates in preventing hemophilic arthropathy. Am J Pediatr Hematol Oncol 1991; 13: 280-7.
13. Nilsson IM, Berntorp E, Löfqvist T, Pettersson H. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B. J Intern Med 1992; 232: 25-32.
14. Aledort LM, Haschmeyer RH, Pettersson H. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group. J Intern Med 1994; 236: 391-9.
15. Chandy M. Treatment Options in the Management of Hemophilia in Developing Countries. World Federation of Hemophilia, Montreal, 2005.
16. World Federation of Hemophilia. Guidelines for the Management of Hemophilia. World Federation of Hemophilia; Montreal, 2005.
17. Giangrande PL, Mariani G, Black C. The WFH Haemophilia Centre Twinning Programme: 10 years of growth, 1993-2003. Haemophilia 2003; 9: 240-4.
18. Evans RG, Barer ML, Marmor TR (eds) Why Are Some People Healthy and Others Not? The Determinants of Health of Populations, Aldine de Gruyter, New York, 1994.